Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Elkhart
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Elkhart, IN

Studies commonly pay $75 to $4,500 per completed study

105 clinical trials are currently recruiting participants within 30 miles of Elkhart. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

105studies recruiting
8+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Elkhart right now

Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Goshen Center for Cancer Care /ID# 257734 — Goshen, Indiana (10.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04928846)

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Lung Non-Small Cell Carcinoma Phase 3 Interventional 336 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07388524)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Midwest Cardiovascu Rsrch Foundation — Elkhart, Indiana (1.0 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 762 participants sought
89bio Clinical Study Site — South Bend, Indiana (14.8 mi) · Sponsor: 89bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06419374)

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Heart Failure Phase 3 Interventional 4,200 participants sought
Midwest Cardiovascular Research and Education Foundation — Elkhart, Indiana (1.0 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT06935370)

An Evidence-based Family Support Program for Parents and Children in Palestine: A Theory-based Intervention

Adolescent, Psychopathology N/A Interventional 900 participants sought
University of NotreDame — Notre Dame, Indiana (14.2 mi) · Sponsor: University of Notre Dame
See eligibility & contact on ClinicalTrials.gov (NCT05706376)

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity Phase 2 Interventional 338 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi) · Sponsor: OHB Neonatology Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT03253263)

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Lakeland Hospital Niles — Niles, Michigan (17.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04510597)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Heart Failure Phase 3 Interventional 11,300 participants sought
Research Site — South Bend, Indiana (14.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06677060)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Elkhart General Hospital — Elkhart, Indiana (1.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment

Alcohol Use Disorder, Opioid Use Disorder N/A Interventional 60 participants sought
The University of Notre Dame — Notre Dame, Indiana (14.2 mi) · Sponsor: University of Notre Dame
See eligibility & contact on ClinicalTrials.gov (NCT07342504)

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Pancreatic Carcinoma, Pancreatic Neoplasm Phase 3 Interventional 274 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06807437)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Heart Failure Phase 3 Interventional 6,712 participants sought
Midwest Cardiovascular Research and Education Foundation — Elkhart, Indiana (1.0 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT06424288)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought
Akero Clinical Study Site — South Bend, Indiana (14.8 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06215716)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07200830)

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia Phase 1, Phase 2 Interventional 84 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: Kartos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04502394)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Colorectal Cancer Stage II, Colorectal Cancer Stage III Phase 3 Interventional 1,057 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT07018869)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Digestive Research Alliance of Michiana — South Bend, Indiana (14.8 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07165028)

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 700 participants sought
Indiana University — Goshen, Indiana (10.0 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT01804686)
Actively enrolling

Studies you may be able to join near Elkhart

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Elkhart

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Indiana Medical Research

303 S Nappanee St, Elkhart, IN 46514
(574) 296-3200

Center for Rare and Neglected Diseases

18885 Moose Krause Cir Galvin Life Sciences Center, Notre Dame, IN 46556
(574) 631-8831

Digestive Research Alliance of Michiana

★ 5.0
53830 Generations Dr Ste 110, South Bend, IN 46635
(574) 393-9755

Velocity Clinical Research

★ 4.5
55 University Dr Ste 106, Valparaiso, IN 46383
(219) 464-8302
"Do go there, 2 minutes to load a card, after you done your part, I say because I'm black."
— Crystal Washington, 1★

LūM Granger

★ 4.8
7221 N Fir Rd, Granger, IN 46530
(574) 968-5166
"These people are some of the most friendly, caring professionals I’ve encountered. Thank you so much"
— Lisa Harkins, 5★

Medical Behavioral Hospital of Mishawaka

★ 2.2 (122 reviews)
1625 E Jefferson Blvd, Mishawaka, IN 46545
(574) 255-1400
"Im not very happy about my "made up" diagnosis. I would like it reversed.<br><br>7 days."
— Richard Hemenway, 1★

Goshen Center for Cancer Care

★ 3.8 (33 reviews)
200 High Park Ave, Goshen, IN 46526
(574) 364-2888
"Dr. Schilder is the best! He keeps my spirits up with his quirky little statements, like Chatty Kathy, he's just the absolute best Dr and I consider …"
— Kathy Hite, 5★

Notre Dame Clinical Law Center

★ 3.5
725 Howard St, South Bend, IN 46617
(574) 631-7795
"It’s just not all it’s cracked up to be . They may and may not help."
— Glen Smarr, 2★

Clinical trials in Elkhart: what's recruiting

The Elkhart area currently has 105 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Elkhart, the most active research areas are:

  • Cancer & Oncology14 studies
  • Liver & Kidney5 studies
  • Heart & Vascular4 studies
  • Diabetes & Metabolism2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Elkhart, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Elkhart

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Elkhart participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Elkhart?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Elkhart?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Elkhart?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Elkhart.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Elkhart typically complete one or two studies per year.

Paid clinical trials near Elkhart

Other metros within reach

South Bend, IN105 Kalamazoo, MI102 Fort Wayne, IN116 Grand Rapids, MI466 Muskegon, MI63 Lafayette, IN34 Chicago, IL2,443 Lansing, MI172

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Elkhart Bladder Issues Due To Spinal Cord Injury in Elkhart All conditions

More of IN

Indianapolis941 Fort Wayne116 South Bend105 Evansville73 Lafayette34

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts